PROVEXIS PLC Logo

PROVEXIS PLC

PXS | IL

Overview

Corporate Details

ISIN(s):
GB00B0923P27
LEI:
21380042E3Y3N9VZ6N48
Country:
United Kingdom
Address:
2 BLAGRAVE STREET, RG1 1AZ READING
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Provexis PLC is a life sciences company specializing in the development, licensing, and sale of scientifically-proven technologies for the functional food, medical food, and dietary supplement sectors. The company's core asset is Fruitflow®, a proprietary and patented natural ingredient clinically proven to support cardiovascular health. Provexis operates a dual business model, licensing Fruitflow® to international food and supplement companies for use in their products, while also marketing its own branded dietary supplements containing Fruitflow® and Omega-3 directly to consumers and through retail partners.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for PROVEXIS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-01-07 14:14
Related Party Transaction
Grant of Options and Warrants
English 32.6 KB
2024-12-31 14:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 13.8 KB
2024-12-31 10:59
Interim Report
Half-year Report
English 212.7 KB
2024-12-18 08:00
Major Shareholding Notification
Purchase of Fruitflow® II SD & royalty payment
English 18.8 KB
2024-10-25 16:47
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 24.2 KB
2024-09-30 08:00
Earnings Release
Final Results
English 384.9 KB
2024-04-30 18:00
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
English 13.7 KB
2024-03-28 08:00
Share Issue/Capital Change
Issue of Equity - purchase of Fruitflow® II SD
English 18.8 KB
2023-12-29 13:48
Earnings Release
Half-year Report
English 198.4 KB
2023-10-26 14:51
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
English 23.8 KB
2023-09-29 08:00
Earnings Release
Final Results
English 374.8 KB
2023-08-30 08:04
Regulatory News Service
BYHEALTH regulatory filing with Chinese SAMR
English 16.5 KB
2023-04-03 08:00
Capital/Financing Update
Capital structure and funding update
English 22.3 KB
2023-01-24 12:03
Remuneration Information
Grant of Share Options
English 34.0 KB
2022-12-30 09:53
Interim Report
Half-year Report
English 203.3 KB

Automate Your Workflow. Get a real-time feed of all PROVEXIS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PROVEXIS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Medesis Pharma S.A. Logo
Biotech creating CNS and oncology therapies using a proprietary drug delivery platform.
France ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
Biotech R&D firm developing novel drugs, devices, and therapies with a focus on oncology.
Poland MDB
Medigene AG Logo
An immuno-oncology platform creating T cell receptor (TCR)-guided therapies to treat cancer.
Germany MDG1
MedinCell S.A. Logo
Develops and licenses long-acting injectable therapies using proprietary technology.
France MEDCL
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR
Mendus Logo
Developing immunotherapies using dendritic cells to prevent recurrence of AML & ovarian cancer.
Sweden IMMU
Merck KGaA Logo United States of America 6MK
Sweden MBOLIC
Milton Essex Spolka Akcyjna Logo
Develops AI-powered, non-invasive systems for allergy diagnostics & personalized medicine.
Poland MTN
Modus Therapeutics Holding AB Logo
Clinical-stage biotech developing sevuparin for sepsis, septic shock, and inflammation.
Sweden MODTX